Positiveid Corp. (PSID) 0.0490 $PSID
PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
GlobeNewswire - Fri Aug 22, 7:30AM CDT
PositiveID's Firefly prototype device could be used to detect viruses such as Ebola and other bio-threats
PositiveID's M-BAND System Shipped to Korea for Testing to Protect U.S. Military
GlobeNewswire - Wed Aug 20, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB
SID), a developer of biological detection and diagnostics solutions, today announced that its M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) system has been sent to the Korean peninsula for continued testing as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR), a program led by the Joint Program Executive Office for Chemical and Biological Defense and supported by the U.S. Army Edgewood Chemical Biological Center, to provide unique biological detection capabilities for advanced bio-surveillance on the Korean peninsula.
PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History
GlobeNewswire - Fri Aug 15, 7:01AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has reported revenue and its smallest operating loss from continuing operations for the first time in the Company's history. The Company's Form 10-Q for the quarter ended June 30, 2014, can be found at: http://investors.positiveidcorp.com/secfiling...IK=1347022.
PositiveID Corporation to Exhibit at the 2014 Military Health System Research Symposium Conference on August 18-21
GlobeNewswire - Wed Aug 13, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it will exhibit at the 2014 Military Health System Research Symposium (MHSRS) Conference on August 18-21, 2014, at the Marriott Harbour Beach Resort in Fort Lauderdale, FL.
Ebola Outbreak Escalates Urgency and Spikes Visibility for Emerging Contender in Biothreat Detection -- PositiveID Corp. Investor Update by SmallCapTraders.com
PR Newswire - Thu Aug 07, 3:01PM CDT
PositiveID Corp. (OTCQB: PSID), with offices in Delray Beach, FL and Pleasanton, CA, is an emerging player in the biothreat detection market. The recent high visibility Ebola outbreak has created significant alarm among government officials as well as industry experts with a steady stream of media coverage flowing out over the last several days as the public follows the story closely. A number of industry experts and potential contenders in the market for diagnostic testing products have surfaced with various opinions and potential solutions with varying degrees of applicability to the near term problem at hand; preventing uncontrolled spread of Ebola (and other bio-threats) that could result in a pandemic or other major public health crisis.
PositiveID's Firefly Dx System Featured on Fox News San Francisco
GlobeNewswire - Thu Aug 07, 9:41AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used for quick Ebola detection, was featured on the Fox news San Francisco affiliate. The clip can be viewed at: http://m.ktvu.com/news/news/health-med-fit-sc...tes/ngxFP/
PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS" Science & Technology directorate, and $30 million of contract funding.
PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract.
PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined).
PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm .
PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies.
Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
PositiveID's Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance
PR Newswire - Mon Jun 16, 7:00AM CDT
(Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions. Mr. Caragol discusses the current status and opportunities for its bio-threat detection technology and recently announced revenue guidance.
Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014.
PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company" (OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations.
PositiveID's Handheld Bio-Threat Testing Device Featured in Computerworld
GlobeNewswire - Fri Aug 22, 7:30AM CDT
PositiveID's Firefly prototype device could be used to detect viruses such as Ebola and other bio-threats
PositiveID's M-BAND System Shipped to Korea for Testing to Protect U.S. Military
GlobeNewswire - Wed Aug 20, 7:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its M-BAND (Microfluidic-based Bioagent Autonomous Networked Detector) system has been sent to the Korean peninsula for continued testing as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR), a program led by the Joint Program Executive Office for Chemical and Biological Defense and supported by the U.S. Army Edgewood Chemical Biological Center, to provide unique biological detection capabilities for advanced bio-surveillance on the Korean peninsula. PositiveID Corporation Reports Revenue From Continuing Operations for First Time in Its History
GlobeNewswire - Fri Aug 15, 7:01AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced it has reported revenue and its smallest operating loss from continuing operations for the first time in the Company's history. The Company's Form 10-Q for the quarter ended June 30, 2014, can be found at: http://investors.positiveidcorp.com/secfiling...IK=1347022. PositiveID Corporation to Exhibit at the 2014 Military Health System Research Symposium Conference on August 18-21
GlobeNewswire - Wed Aug 13, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that it will exhibit at the 2014 Military Health System Research Symposium (MHSRS) Conference on August 18-21, 2014, at the Marriott Harbour Beach Resort in Fort Lauderdale, FL. Ebola Outbreak Escalates Urgency and Spikes Visibility for Emerging Contender in Biothreat Detection -- PositiveID Corp. Investor Update by SmallCapTraders.com
PR Newswire - Thu Aug 07, 3:01PM CDT
PositiveID Corp. (OTCQB: PSID), with offices in Delray Beach, FL and Pleasanton, CA, is an emerging player in the biothreat detection market. The recent high visibility Ebola outbreak has created significant alarm among government officials as well as industry experts with a steady stream of media coverage flowing out over the last several days as the public follows the story closely. A number of industry experts and potential contenders in the market for diagnostic testing products have surfaced with various opinions and potential solutions with varying degrees of applicability to the near term problem at hand; preventing uncontrolled spread of Ebola (and other bio-threats) that could result in a pandemic or other major public health crisis.
PositiveID's Firefly Dx System Featured on Fox News San Francisco
GlobeNewswire - Thu Aug 07, 9:41AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Firefly Dx system, designed to deliver molecular diagnostic results rapidly at the point-of-need, which could be used for quick Ebola detection, was featured on the Fox news San Francisco affiliate. The clip can be viewed at: http://m.ktvu.com/news/news/health-med-fit-sc...tes/ngxFP/ PositiveID Analyst Inspection: Emerging Contender in BioThreat Detection - First Ever Revenue Guidance and Backlog Position Company for Increased Visibility and Traction - by SmallCapTraders.com
PR Newswire - Wed Jul 23, 8:30AM CDT
PositiveID Corp. (OTCQB: PSID), based in Delray Beach, Fla., is an emerging player in the bio-threat detection market, that develops molecular diagnostic systems for bio-threat detection and rapid medical testing. The Company's proprietary airborne pathogen detection system called M-BAND (Microfluidic Bio-agent Autonomous Networked Detector), was developed under contract with the U.S. Department of Homeland Security ("DHS"
Science & Technology directorate, and $30 million of contract funding. PositiveID wins new purchase order to support M-BAND System for US government to protect the nation's warfighters and defenders
M2 - Fri Jul 18, 9:56AM CDT
Biological detection company PositiveID (Other OTC
SID) disclosed on Thursday the receipt of a new purchase order for the continued testing and evaluation of its M-BAND (Microfluidic Bioagent Autonomous Networked Detector) from a large government contractor in support of an existing US government contract. PositiveID Receives New Order to Support M-BAND System for U.S. Government Contract
GlobeNewswire - Thu Jul 17, 6:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that it has received a new order from a large government contractor for the continued testing and evaluation of PositiveID's M-BAND (Microfluidic Bioagent Autonomous Networked Detector) in support of an existing U.S. government contract. In keeping with contractual obligations the contractor and program have not been named. As a result of this new purchase order, the company has increased its 2014/2015 revenue and backlog (backlog added to revenue recognized) estimate from $3.3 million to $3.5 million, and is reiterating its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined). PositiveID Corp. Chairman and CEO William J. Caragol Conducts New Interview with The Green Baron Report
GlobeNewswire - Tue Jul 01, 7:11AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, announced today that its Chairman and CEO William J. Caragol has conducted a new, audio-taped webcast interview with The Green Baron Report. In the interview, Mr. Caragol provides an update for PositiveID's stockholders and the investment community on the Company's recent developments and growth plans. Unrestricted access to the webcast is now available on the "Webcasts" page at http://www.thegreenbaron.com/Webcasts.htm . PositiveID Publishes Updated Report on Its BioThreat Detection and Diagnostics Solutions and Market Opportunities
GlobeNewswire - Mon Jun 30, 6:00AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today published an updated report on its 2014 progress and future market opportunities for its homeland security and medical diagnostics technologies. Quality Systems Teams Up With 3M Health Information Systems - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:50PM CDT
Quality Systems (QSII) continues to report a fall in earnings and revenues but we are still optimistic about the company given the continued strength in its NextGen subsidiary as well as the expected benefit from its Mirth acquisition.
Cerner Enters New Agreement with North Carolina's Mission Health - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Jun 25, 12:40PM CDT
Under the new agreement, signed on Mar 28, Cerner Corporation (CERN) will help Mission Health control IT costs, align strategies, and improve the quality of care.
St. Jude Medical Hits New 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jun 23, 2:45PM CDT
Considering the last one month, shares of St. Jude Medical (STJ) returned 8.9%, higher than the S&P 500 return of 5.0%.
St. Jude Medical Gets Award for Leadless Pacemaker - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 20, 12:10PM CDT
A congress committee of electrophysiologists has chosen St. Jude Medical's (STJ) Nanostim leadless pacemaker for the award being the most innovative product in electrophysiology and cardiac technique
PositiveID's Chairman and CEO Discusses Progress with Bio-Threat Detection Technology and Revenue Guidance
PR Newswire - Mon Jun 16, 7:00AM CDT
(Investorideas.com Newswire) Investorideas.com, a leader in research for independent investors presents an exclusive Q&A interview with Mr. William J. Caragol, Chairman and Chief Executive Officer of PositiveID Corporation (OTCBB: PSID), a developer of biological detection and diagnostics solutions. Mr. Caragol discusses the current status and opportunities for its bio-threat detection technology and recently announced revenue guidance.
Limitless Venture Group's Stock Volume Soars On News of Hemp-Based Products
ACCESSWIRE - Wed Apr 02, 8:41AM CDT
Limitless Venture Group Inc.'s (OTCPINK: LVGI) stock volume skyrocketed Apr. 1, with 292,012,825 shares changing hands, nearly three times more than its three-month average volume of 107,767,353 shares.
The Market and Potential for Molecular Point of Care Diagnostics Report Provides Market Estimates up to 2018
M2 - Mon Mar 31, 11:27AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gb6tbz/the_market_and) has announced the addition of the "The Market and Potential for Molecular Point of Care Diagnostics" report to their offering. The molecular diagnostic market and the point-of-care (POC) testing markets are two of the fastest growing segments of the overall IVD market. Historically, these have been completely different market segments. Not anymore. There has been a growing interest in developing molecular diagnostic platforms that can be used in POC settings. Indeed, as this new market research report details, the emerging area of rapid molecular POC testing has attracted over $650 million in investments and financings over the past five years (2009 to 2013). The Market and Potential for Molecular Point of Care Diagnostics, offers a quantitative assessment of the molecular diagnostic market, and of the point-of-care (POC) testing market, and then looks at the emerging field of molecular diagnostic POC testing. Many companies are developing molecular diagnostic platforms and assays that are designed to for near-patient or POC testing, and the earliest of these systems are starting to reach the market. The initial market focus for most of these companies is on infectious disease testing, where rapid test results generate important actionable information that physicians can use to make treatment decisions. Over 75 companies involved in this market are profiled in this report. As expected with any group of start-up companies, many are struggling or are surviving on limited financial resources. However, some new companies that are focusing on molecular diagnostic POC testing have received significant investments. Some of the Companies Mentioned: - Abacus Diagnostica Oy - bioMerieux sa - Canon U.S. Life Sciences - DiaSorin S.p.A. - Espira, Inc. - Focus Diagnostics, Inc. - GenePOC Inc. - Instrumentation Laboratory - Lumora Ltd - Meridian Bioscience, Inc. - NetBio, Inc. - OptiGene Ltd. - PositiveID Corporation - QIAGEN N.V - Spartan Bioscience Inc. - Veredus Laboratories - Wave 80 Biosciences - Xagenic Inc. For more information visit http://www.researchandmarkets.com/research/gb...market_and About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
PositiveID Signs Agreement With Unit of UTC Aerospace Systems for U.S. Government Contract
GlobeNewswire - Mon Mar 31, 7:30AM CDT
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, is proud to announce that it has signed a contract with UTC Aerospace Systems' ISR & Space Systems unit to support a contract for the U.S. Department of Defense ("DoD" . This contract is expected to be performed over the next seven months, between March and September, 2014. PositiveID Corporation's CEO to Present at InvestorIdeas.com Security and Defense Conference on March 11, 2014 in New York City
GlobeNewswire - Wed Mar 05, 7:42AM CST
PositiveID Corporation ("PositiveID" or "Company"
(OTCQB SID), a developer of biological detection and diagnostics solutions, today announced that its Chairman and CEO, William J. Caragol, will present at the InvestorIdeas.com Security and Defense Conference at 3:30 pm on March 11, 2014, at the New York Hilton Midtown in New York City. The Company's presentation will be posted in the Investors & Media section of its website under Events & Presentations. 
